[Cortisone treatment of arteriosclerotic chorioretinopathy - a catamnestic study (author's transl)].
Visual acuity was tested in 34 patients (64 eyes), age 73.6 years, following systemic cortisone administration. A significant improvement in vision was found (82.81% and 67.19%) after three as well as after an average of ten months. It is remarkable that some of the patients (17 eyes), who were treated with vessel-active substances, and in some cases also with the vitamins A and E, also showed improvement in visual acuity comparable with the group treated with cortison only. In the small group (six eyes) with moist macular degeneration a slight improvement was only recorded in one case. The probable effects of cortisone in the course of arteriosclerotic chorioretinopathy are explained with the aid of histological findings of other authors.
D000368:Aged; D001161:Arteriosclerosis / Q000188:drug therapy*; D002829:Choroid; D003348:Cortisone / Q000627:therapeutic use*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008268:Macular Degeneration / Q000150:complications / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D012164:Retinal Diseases / Q000188:drug therapy*; D014603:Uveal Diseases / Q000188:drug therapy; D014792:Visual Acuity / Q000187:drug effects*
D003348:Cortisone
Zur Cortisonbehandlung der arteriosklerotischen Chorioretinopathie - eine katamnestische Studie.